BridgeBio Pharma Derivative Contract Liabilities (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

66.54 -1.77 (-2.59%) USD | NASDAQ | Feb 25, 16:00

67.13 +0.59 (+0.89%) After-Hours: 20:00

View Derivative Contract Liabilities (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Mirum Pharmaceuticals, Inc.	--
Cogent Biosciences, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Sarepta Therapeutics, Inc.	--